Foundations Investment Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,190
Closed -$262K 1201
2025
Q4
$262K Sell
3,190
-100
-3% -$7.79K ﹤0.01% 941
2025
Q3
$247K Sell
3,290
-235
-7% -$17.5K ﹤0.01% 924
2025
Q2
$261K Sell
3,525
-1,223
-26% -$85.1K ﹤0.01% 790
2025
Q1
$383K Buy
4,748
+1,197
+34% +$103K 0.01% 645
2024
Q4
$278K Buy
3,551
+424
+14% +$36K 0.01% 678
2024
Q3
$293K Buy
3,127
+40
+1% +$3.36K 0.01% 638
2024
Q2
$241K Buy
3,087
+276
+10% +$22.5K 0.01% 672
2024
Q1
$256K Sell
2,811
-204
-7% -$17K 0.01% 622
2023
Q4
$224K Sell
3,015
-12
-0.4% -$840 0.01% 618
2023
Q3
$206K Sell
3,027
-1,841
-38% -$134K 0.01% 610
2023
Q2
$395K Buy
+4,868
New +$388K 0.01% 409

Other funds holding GEHC

Foundations Investment Advisors's GEHC Position: Q1 2026 in Review

Foundations Investment Advisors sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 3,190 shares — an estimated $262K sold.

Foundations Investment Advisors first reported a position in GEHC in Q2 2023 and held it in 11 quarters. The position peaked at $395K in Q2 2023. 1,272 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Foundations Investment Advisors reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Foundations Investment Advisors sold 3,190 GE HealthCare shares in Q1 2026, an estimated $262K.
  • Foundations Investment Advisors first reported a position in GE HealthCare in Q2 2023 and held it in 11 quarters.
  • Foundations Investment Advisors's GE HealthCare position peaked at $395K in Q2 2023.
  • 1,272 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Foundations Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.